| List Name |
Annotation |
Enrichment |
p-value |
| T-helper 1 type immune response |
AmiGO Browser |
26.97 |
2.46e-03 |
| alpha-beta T cell differentiation during immune response |
AmiGO Browser |
23.80 |
3.16e-03 |
| T cell activation during immune response |
AmiGO Browser |
23.80 |
3.16e-03 |
| CD4-positive, alpha-beta T cell differentiation during immune response |
AmiGO Browser |
23.80 |
3.16e-03 |
| leukocyte activation during immune response |
AmiGO Browser |
23.80 |
3.16e-03 |
| lymphocyte activation during immune response |
AmiGO Browser |
23.80 |
3.16e-03 |
| cell activation during immune response |
AmiGO Browser |
23.80 |
3.16e-03 |
| T cell differentiation during immune response |
AmiGO Browser |
23.80 |
3.16e-03 |
| T-helper cell differentiation |
AmiGO Browser |
23.80 |
3.16e-03 |
| CD4-positive, alpha beta T cell differentiation |
AmiGO Browser |
21.29 |
3.95e-03 |
| alpha-beta T cell differentiation |
AmiGO Browser |
14.45 |
8.48e-03 |
| ribonucleoside monophosphate biosynthetic process |
AmiGO Browser |
13.48 |
9.70e-03 |
| ribonucleoside monophosphate metabolic process |
AmiGO Browser |
13.48 |
9.70e-03 |
| nucleoside monophosphate metabolic process |
AmiGO Browser |
12.64 |
0.01 |
| nucleoside monophosphate biosynthetic process |
AmiGO Browser |
12.64 |
0.01 |
| alpha-beta T cell activation |
AmiGO Browser |
11.24 |
0.01 |
| ribonucleotide biosynthetic process |
AmiGO Browser |
5.72 |
0.02 |
| DNA integration |
AmiGO Browser |
50.57 |
0.02 |
| ribonucleotide metabolic process |
AmiGO Browser |
4.97 |
0.02 |
| endosome transport |
AmiGO Browser |
8.09 |
0.03 |
| androgen receptor signaling pathway |
AmiGO Browser |
7.49 |
0.03 |
| lymphocyte costimulation |
AmiGO Browser |
28.90 |
0.03 |
| T cell costimulation |
AmiGO Browser |
28.90 |
0.03 |
| central nervous system neuron development |
AmiGO Browser |
28.90 |
0.03 |
| metabolic compound salvage |
AmiGO Browser |
25.28 |
0.04 |
| sister chromatid cohesion |
AmiGO Browser |
22.47 |
0.04 |
| regulation of cell volume |
AmiGO Browser |
22.47 |
0.04 |
| purine ribonucleoside metabolic process |
AmiGO Browser |
20.23 |
0.05 |
| purine nucleoside metabolic process |
AmiGO Browser |
20.23 |
0.05 |
| central nervous system neuron differentiation |
AmiGO Browser |
20.23 |
0.05 |
| heparan sulfate proteoglycan biosynthetic process |
AmiGO Browser |
18.39 |
0.05 |
| chromatin assembly or disassembly |
AmiGO Browser |
3.55 |
0.05 |
| Golgi to endosome transport |
AmiGO Browser |
16.86 |
0.06 |
| endoderm development |
AmiGO Browser |
16.86 |
0.06 |
| negative regulation of axon extension |
AmiGO Browser |
16.86 |
0.06 |
| microtubule nucleation |
AmiGO Browser |
16.86 |
0.06 |
| positive regulation of gene expression, epigenetic |
AmiGO Browser |
16.86 |
0.06 |
| ribonucleoside metabolic process |
AmiGO Browser |
16.86 |
0.06 |
| chromosome segregation |
AmiGO Browser |
5.12 |
0.06 |
| T cell differentiation |
AmiGO Browser |
4.99 |
0.06 |
| galactose metabolic process |
AmiGO Browser |
15.56 |
0.06 |
| regulation of T-helper cell differentiation |
AmiGO Browser |
15.56 |
0.06 |
| nucleotide biosynthetic process |
AmiGO Browser |
3.32 |
0.06 |
| Golgi vesicle transport |
AmiGO Browser |
3.32 |
0.06 |
| steroid hormone receptor signaling pathway |
AmiGO Browser |
4.87 |
0.06 |
| heparan sulfate proteoglycan metabolic process |
AmiGO Browser |
14.45 |
0.07 |
| intracellular receptor-mediated signaling pathway |
AmiGO Browser |
4.60 |
0.07 |
| indole and derivative metabolic process |
AmiGO Browser |
13.48 |
0.07 |
| negative regulation of axonogenesis |
AmiGO Browser |
13.48 |
0.07 |
| indole derivative metabolic process |
AmiGO Browser |
13.48 |
0.07 |
| indolalkylamine metabolic process |
AmiGO Browser |
13.48 |
0.07 |
| oligosaccharide biosynthetic process |
AmiGO Browser |
13.48 |
0.07 |
| DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis |
AmiGO Browser |
12.64 |
0.08 |
| purine base metabolic process |
AmiGO Browser |
12.64 |
0.08 |
| nucleosome assembly |
AmiGO Browser |
4.35 |
0.08 |
| purine ribonucleotide biosynthetic process |
AmiGO Browser |
4.30 |
0.08 |
| specification of organ identity |
AmiGO Browser |
11.90 |
0.08 |
| cell-cell signaling during cell fate commitment |
AmiGO Browser |
11.90 |
0.08 |
| induction of an organ |
AmiGO Browser |
11.90 |
0.08 |
| induction |
AmiGO Browser |
11.90 |
0.08 |
| positive regulation of interleukin-2 biosynthetic process |
AmiGO Browser |
11.90 |
0.08 |
| meiosis |
AmiGO Browser |
4.17 |
0.08 |
| M phase of meiotic cell cycle |
AmiGO Browser |
4.17 |
0.08 |
| meiotic cell cycle |
AmiGO Browser |
4.13 |
0.09 |
| purine nucleotide biosynthetic process |
AmiGO Browser |
4.05 |
0.09 |
| nucleobase biosynthetic process |
AmiGO Browser |
10.65 |
0.09 |
| heterocycle metabolic process |
AmiGO Browser |
3.97 |
0.09 |
| purine nucleoside monophosphate metabolic process |
AmiGO Browser |
10.11 |
0.09 |
| purine nucleoside monophosphate biosynthetic process |
AmiGO Browser |
10.11 |
0.09 |
| purine ribonucleoside monophosphate metabolic process |
AmiGO Browser |
10.11 |
0.09 |
| negative regulation of neurogenesis |
AmiGO Browser |
10.11 |
0.09 |
| purine ribonucleoside monophosphate biosynthetic process |
AmiGO Browser |
10.11 |
0.09 |
| nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
1.31 |
0.10 |
| cell aging |
AmiGO Browser |
9.63 |
0.10 |
| mRNA polyadenylation |
AmiGO Browser |
9.63 |
0.10 |
| regulation of interleukin-2 biosynthetic process |
AmiGO Browser |
9.63 |
0.10 |
| chromatin assembly |
AmiGO Browser |
3.75 |
0.10 |
| purine ribonucleotide metabolic process |
AmiGO Browser |
3.75 |
0.10 |
| male gamete generation |
AmiGO Browser |
2.70 |
0.10 |
| spermatogenesis |
AmiGO Browser |
2.70 |
0.10 |
| release of cytochrome c from mitochondria |
AmiGO Browser |
9.19 |
0.10 |
| transmembrane receptor protein tyrosine phosphatase signaling pathway |
AmiGO Browser |
9.19 |
0.10 |
| cell fate commitment |
AmiGO Browser |
3.64 |
0.10 |
L2L Microarray Analysis Tool